The Impact of Abdominal Wall Closure Technique on Incidence of Incisional Hernia in Kidney Transplantation
NCT ID: NCT03959904
Last Updated: 2025-05-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
50 participants
INTERVENTIONAL
2020-03-10
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Laparoscopic Incisional Hernia Repair in Liver Transplant Patients
NCT02123719
HErnias REparation After Kidney Transplantation Study
NCT04730492
Giant Ventral Incisional Hernia: Abdominal Wall Function, Respiratory Performance and Quality of Life
NCT02011048
Suture Techniques to Reduce the Incidence of Incisional Hernia: LTFU STITCH Trial
NCT06066385
Prophylactic Mesh in Cytoreductive Surgery
NCT03953365
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
STUDY SETTING The study will be carried out on one site at Manchester Royal Infirmary, part of Manchester University National Health Service (NHS) Foundation Trust. This is a regional Renal and Pancreas Transplant centre performing approximately 60 pancreas transplants per annum and 350 kidney transplants. All members of the team have academic track records and participate in several on-going research projects. Current research projects are investigating cardiovascular disease, kidney perfusion, Magnetic Resonance (MR) imaging to name a few.
RESEARCH QUESTIONS, AIMS, AND OBJECTIVES
Phase 1 To retrospectively evaluate the incidence of incisional hernias in our transplant population and associated risk factors.
Phase 2
1. To perform prospective randomized double blinded feasibility trial to investigate the use of "small bites" (SB) vs "large bites (LB)" for closure of abdominal incisions following kidney transplantation.
2. To collect detailed medical histories from all patients included in the study to look for potential medical risk factors which may predispose to hernia formation.
3. To collect tissue and blood samples to investigate potential biological and histological markers of hernia formation, from both patients with end stage renal failure receiving a living-donor kidney transplant, and samples from the donor nephrectomy patients for histological comparison.
4. To assess quality of life and pain scores in the early and delayed post-operative phase (week 1, 6 months and 1 year)
Outcomes Phase 1 Incidence of Incisional Hernia within 1 and 3 years post-transplant clinically or radiologically detected.
Phase 2 Primary outcome Incidence of Incisional Hernia within one year post transplant, either clinically or radiologically detected. Any incisional hernia identified will be classified as per European Hernia Society Guidelines.
Secondary outcomes Incidence of post-operative complications at 6 months post op (burst abdomen, chest infection, surgical site infection returns to theatre,etc), pain score, costs, length of hospital stay, quality of life at week 1, 6 and 12 months post-transplant, collagen and serum biomarkers which may predispose to hernia formation
Sampling and recruitment Sample identification Phase 1 Data will be collected from the medical records of our Transplant population and entered into an excel spreadsheet no personal identifiers will be recorded.
Phase 2 The Chief Investigator (CI) and Principle Investigator (PI) will identify patients on the transplant waiting list and send copies of the information sheet.
Following ethical approval, patients undergoing first or second renal transplantation will be asked for informed consent to participate in the study to receive either small or large bites.
The CI and PI are part of the direct care team. The CI will have custody of the clinical information.
Clinical details will be recorded on hospital pass worded computers. Blood samples will be anonymised at the time of collection. Patients will be given a study code and blood samples will be labelled with this code to ensure anonymity.
The custodian of the data and samples will be the CI.Mr David van Dellen.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Small Stitch
Small stitch for wound closure
Small stitch
Wound closure will be using small stiches or larger spaced stitches
Blood sample
A blood sample to look for biological markers of Hernia formation will be taken
Tissue Sample
A tissue sample will be taken to measure markers of wound healing.
Pain Score
A pain score will be recorded following the surgical procedure.
Quality of Life Score
A Quality of Life Score will be recorded at 1 month 6 months and 12 months post surgery
Large Stitch
Large Stitch for wound closure
Small stitch
Wound closure will be using small stiches or larger spaced stitches
Blood sample
A blood sample to look for biological markers of Hernia formation will be taken
Tissue Sample
A tissue sample will be taken to measure markers of wound healing.
Pain Score
A pain score will be recorded following the surgical procedure.
Quality of Life Score
A Quality of Life Score will be recorded at 1 month 6 months and 12 months post surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Small stitch
Wound closure will be using small stiches or larger spaced stitches
Blood sample
A blood sample to look for biological markers of Hernia formation will be taken
Tissue Sample
A tissue sample will be taken to measure markers of wound healing.
Pain Score
A pain score will be recorded following the surgical procedure.
Quality of Life Score
A Quality of Life Score will be recorded at 1 month 6 months and 12 months post surgery
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged 18-70yrs
* First transplants or second transplants
* Ability to adequately understand English and consent for study
* BMI\<35 kg/m2)
Exclusion Criteria
* Previous transplants which have left a scar in the ilia fossa
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Manchester University NHS Foundation Trust
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Manchester University NHS Foundation Trust
Manchester, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Angela Summers
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B00469
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.